Antigen recognition. Editorial overview

Current Opinion in Immunology

Volumn 9, Issue 1, 1997, Pages 71-74

  Cresswell, Peter ^a   Howard, Jonathan C ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; B LYMPHOCYTE; CELL; KILLER CELL; NATURAL KILLER CELL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; EDITORIAL; HUMAN; METABOLISM;

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ANIMALS; ANTIGEN PRESENTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS;

EID: 0031066805     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(97)80161-6     Document Type: Editorial

References (26)

1. Smith KJ, Reid SW, Harlos K, McMichael AJ, Stuart DI, Bell JI, Jones EY. Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. Immunity. 4:1996;215-228.
2. Fremont DH, Stura EA, Matsumura M, Peterson PA, Wilson IA. Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc Natl Acad Sci USA. 92:1995;2479-2483.
3. + 3501. Immunity. 4:1996;203-213.
4. Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC. Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. Proc Natl Acad Sci USA. 93:1996;734-738.
5. Fremont DH, Hendrickson WA, Marrack P, Kappler J. Structures of an MHC class II molecule with convalently bound single peptides. Science. 272:1996;1001-1004.
6. Groettrup M, Soza A, Eggers M, Kuehn L, Dick TP, Schild H, Rammensee H-G, Koszinowski UH, Kloetzel P-M. A role for the protease regulator PA28a in antigen presentation. Nature. 381:1996;166-168.
7. Dick TP, Ruppert T, Groettrup M, Kloetzel PM, Kuehn L, Koszinowski UH, Stevanovic S, Schild H, Rammensee H-G. Coordinated dual cleavage induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell. 86:1996;253-262.
8. Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity. 5:1996;103-114.
9. Grandea AG III, Androlewicz MJ, Athwal RS, Geraghty DE, Spies T. Dependence of peptide binding by MHC class I molecules on their interaction with ATP. Science. 270:1995;105-108.
10. Ghosh P, Amaya M, Mellins E, Wiley DC. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature. 378:1995;457-462.
11. Weber DA, Evavold BD, Jensen PE. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science. 274:1996;618-620.
12. Liljedahl M, Kuwana T, Fung-Leung W-P, Jackson MR, Peterson PA, Karlsson L. HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. EMBO J. 15:1996;4817-4824.
13. Bevec T, Stoka V, Pungercic G, Dolenc I, Turk V. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L. J Exp Med. 183:1996;1331-1338.
14. Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, Peterson PA, Teyton L, Wilson IA. An αβ T cell receptor structure at 2.5Å and its orientation in the TCR-MHC complex. Science. 274:1996;209-219.
15. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature. 384:1996;134-141.
16. Deeg HJ, Wulff JC, Derose S, Sale GE, Braun M, Brown MA, Springmeyer SC, Martin PJ, Storb R. Unusual distribution of la-like antigens on canine lymphocytes. Immunogenetics. 16:1982;445-457.
17. Kaufman J, Völk H, Wallny H-J. A "minimal essential Mhc" and an "unrecognized Mhc": two extremes in selection for polymorphism. Immunol Rev. 143:1995;63-88.
18. Darnell JE Jr, Kerr IM, Stark GR. JAK-STAT pathways and transcriptional activation in response to IFNs and other extracellular signalling proteins. Science. 264:1994;1415-1421.
19. Mond JJ, Carman J, Sarma C, Ohara J, Finkelman FD. Interferon-gamma suppresses B cell stimulation factor (BSF-1) induction of class II determinants on B cells. J Immunol. 137:1986;3534-3537.
20. Li Z, Dordai DI, Lee J, Desiderio S. A conserved degradation signal regulates RAG-2 accumulation during cell division and links V(D)J recombination to the cell cycle. Immunity. 5:1996;575-589.
21. Stanhope-Baker P, Hudson KM, Shaffer AL, Constantinescu A, Schlissel MS. Cell type-specific chromatin structure determines the targeting of V(D)J recombination activity in vitro. Cell. 85:1996;887-897.
22. Schwarz K, Gauss GH, Ludwig L, Pannike U, Li Z, Lindner D, Friedrich W, Seger RA, Hansen-Hagge TE, Desiderio S, et al. RAG mutations in human B cell-negative SCID. Science. 274:1996;97-99.
23. Brambell FWR, Hemmings WA, Morris IG. A theoretical model of γ-globulin catabolism. Nature. 203:1964;1352-1355.
24. Brambell FWR. The transmission of immunity from mother to young and the catobolism of imunoglobulins. Lancet. ii:1966;1087-1093.
25. Fahnestock ML, Johnson JL, Feldman RMR, Neveu JM, Lane WS, Bjorkman PJ. The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity. 3:1995;583-590.
26. Kubagawn H, Burrows PD, Copper MD. A new gene family expressed by B and myeloid cells. Abstract Keystone Symposia on B Lymphocytes in Health and Disease. 1997 January;3. Steamboat Springs, Colorado.